Treating tubal factor infertility
Tubal disease, a disorder in which the fallopian tubes are blocked or damaged, is responsible for approximately 25 to 35 percent of all female factor infertility.
Tubal disease, a disorder in which the fallopian tubes are blocked or damaged, is responsible for approximately 25 to 35 percent of all female factor infertility.
Updated by the Progyny Editorial Team — December 2025. Balancing fertility treatment with work can feel overwhelming. Medical appointments, hormone […]
Updated by the Progyny Editorial Team. Reviewed by the Progyny Clinical Team — December 2025. Embryo transfers can be exciting and nerve-wracking at […]
Written by the Progyny Editorial Team — December 2025. Starting fertility treatment is a big step and choosing a clinic is […]
Updated by the Progyny Editorial Team and reviewed by Dr. Janet Choi, Chief Medical Officer, Progyny — November 2025. If […]
Updated by the Progyny Clinical Team — September 2025. Polycystic ovary syndrome (PCOS) is a common hormonal condition that affects […]
Progyny hosted a webinar on how people can navigate the holidays or family gatherings while on their path to parenthood.
Progyny hosted a webinar on how people can navigate the holidays or family gatherings while on their path to parenthood.
Progyny hosted a webinar about understanding the health conditions that increase infertility in the Black community and finding the right doctor. We expanded the dialogue we started with our Fertility and Maternal Health in the Black Community webinar by pulling together experts to discuss the health conditions specific to the Black community and insights for finding a physician you connect with.
Receiving a cancer diagnosis can turn your world upside down, but understanding your fertility options from day one can make all the difference.
How clinics are keeping you safe and what fertility treatment will look like during COVID and beyond.
Black women are twice as likely to suffer from infertility but are half as likely to access care than white women.